The Drug-Induced Respiratory Disease Website and App

Hemodialysis - Chronic renal replacement therapy

Frequency - Incidence

Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases

Evidence level/grade

Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic

I.i

Diffuse pulmonary calcification (calciphylaxis)

Publications

Belém LC, Zanetti G, Souza AS Jr, Hochhegger B, Guimarães MD, Nobre LF, Rodrigues RS, Marchiori E

Metastatic pulmonary calcification: state-of-the-art review focused on imaging findings.

Respiratory medicine. 2014;108(5):668-76

Madhusudhan KS, Shad PS, Sharma S, Goel A, Mahajan H

Metastatic pulmonary calcification in chronic renal failure.

International urology and nephrology. 2012;44(4):1285-7

Eggert CH, Albright RC

Metastatic pulmonary calcification in a dialysis patient: case report and a review.

Hemodialysis international. International Symposium on Home Hemodialysis. 2006;10 Suppl 2:S51-5